FOIA Number: 2013-0365-F FOIA MARKER This is not a textual record. This is used as an administrative marker by the William J. Clinton Presidential Library Staff. Collection/Record Group: Clinton Presidential Records Subgroup/Office of Origin: Records Management - SUBJECT FILE Series/Staff Member: Subject Files Subseries: OA/ID Number: 21908 Scan ID: 296995 [2] Document Number: Folder Title: FA004 Stack: Row: Section: Shelf: Position: 83 6 THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generaied ic LPWJC "^^dr.. Donald A. Glaser Department of Molecular & Cell Biology University of California, Berkeley Suite 3206 229 Stanley Hall Berkeley, California 94720-3206 Dear Donald: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated by LPWJC Joseph L. Goldstein Department of Molecular Genetics University of Texas Southwestern Medical Center 5323 Harry Hines Boulevard Dallas, Texas 75232-9046 Dear Joseph: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated by LPWJC Roger Guillemin The Salk Institute for Biological Studies 7316 Encelia Drive La Jolla, California 92037 Dear Roger: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated by LPWJC ?rbfeeeer Dudley Herschbach Department of Chemistry Harvard University 12 Oxford Street Cambridge, Massachusetts 02138 Dear Dudley: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON Paper Copy Generated by December 16, 1999 LPWJC <^Tirofcaoor David H. Hubel Cf^5^fes"sqr_J:l^^ Npnrnm n1 nny John Franklin Enders University Harvard Medical School 25 Shattuck Street Boston, Massachusetts 02115-6092 Dear David: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated by LPWJC ^^se^^ssCT Arthur Kornberg Professor of Biochemistry Stanford University Medical Center Suite M121 300 Pasteur Drive Stanford, California 94305-5119 Dear Arthur: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated by LPWJC ^^rofooDO^r Edwin G. Krebs Professor Emeritus Department of Pharmacology University of Washington Box 357280 Seattle, Washington 98195 Dear Edwin: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated LPWJC Joshua Lederberg President ^^ocew^^ The Rockefeller University 123 0 York Avenue New York, New York 10021-6399 Dear Joshua: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's